21 janvier 2021 – EMA has endorsed a joint statement published on 19 January 2021 by the International Coalition of Medicines Regulatory Authorities (ICMRA) to inform and help healthcare professionals answer questions about the evaluation, approval and monitoring of safe, effective and high-quality COVID-19 vaccines. In their joint statement, international regulators explain how COVID-19 vaccines undergo scientific evaluation to determine their safety, efficacy and quality. They also reiterate that regulators continue to rigorously monitor the safety of vaccines after approval for use. ICMRA members emphasise that regulators, in collaboration with public health authorities, are able to take decisive action if and when a safety issue is identified.

For further information see here.